nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Tiotropium—SLC22A5—dilated cardiomyopathy	0.0572	0.656	CrCbGaD
Methylscopolamine bromide—Ipratropium bromide—SLC22A5—dilated cardiomyopathy	0.03	0.344	CrCbGaD
Methylscopolamine bromide—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0234	0.0609	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0227	0.059	CcSEcCtD
Methylscopolamine bromide—Confusional state—Spironolactone—dilated cardiomyopathy	0.0146	0.0379	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0145	0.0376	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Furosemide—dilated cardiomyopathy	0.0139	0.0362	CcSEcCtD
Methylscopolamine bromide—Somnolence—Spironolactone—dilated cardiomyopathy	0.0129	0.0334	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Furosemide—dilated cardiomyopathy	0.0123	0.0321	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0119	0.031	CcSEcCtD
Methylscopolamine bromide—Urticaria—Spironolactone—dilated cardiomyopathy	0.0115	0.0299	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0107	0.0277	CcSEcCtD
Methylscopolamine bromide—Dizziness—Spironolactone—dilated cardiomyopathy	0.00956	0.0249	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00956	0.0249	CcSEcCtD
Methylscopolamine bromide—Vomiting—Spironolactone—dilated cardiomyopathy	0.0092	0.0239	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Furosemide—dilated cardiomyopathy	0.00909	0.0236	CcSEcCtD
Methylscopolamine bromide—Headache—Spironolactone—dilated cardiomyopathy	0.00906	0.0236	CcSEcCtD
Methylscopolamine bromide—Nausea—Spironolactone—dilated cardiomyopathy	0.00859	0.0223	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Furosemide—dilated cardiomyopathy	0.00803	0.0209	CcSEcCtD
Methylscopolamine bromide—Confusional state—Furosemide—dilated cardiomyopathy	0.00793	0.0206	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00787	0.0205	CcSEcCtD
Methylscopolamine bromide—Tension—Lisinopril—dilated cardiomyopathy	0.0071	0.0185	CcSEcCtD
Methylscopolamine bromide—Nervousness—Lisinopril—dilated cardiomyopathy	0.00703	0.0183	CcSEcCtD
Methylscopolamine bromide—Somnolence—Furosemide—dilated cardiomyopathy	0.00699	0.0182	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00682	0.0177	CcSEcCtD
Methylscopolamine bromide—Constipation—Furosemide—dilated cardiomyopathy	0.00673	0.0175	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00648	0.0169	CcSEcCtD
Methylscopolamine bromide—Palpitations—Lisinopril—dilated cardiomyopathy	0.00639	0.0166	CcSEcCtD
Methylscopolamine bromide—Urticaria—Furosemide—dilated cardiomyopathy	0.00625	0.0163	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00602	0.0157	CcSEcCtD
Methylscopolamine bromide—Confusional state—Lisinopril—dilated cardiomyopathy	0.00595	0.0155	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.0059	0.0154	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0058	0.0151	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00576	0.015	CcSEcCtD
Methylscopolamine bromide—Asthenia—Furosemide—dilated cardiomyopathy	0.00565	0.0147	CcSEcCtD
Methylscopolamine bromide—Insomnia—Lisinopril—dilated cardiomyopathy	0.00534	0.0139	CcSEcCtD
Methylscopolamine bromide—Somnolence—Lisinopril—dilated cardiomyopathy	0.00525	0.0136	CcSEcCtD
Methylscopolamine bromide—Dizziness—Furosemide—dilated cardiomyopathy	0.0052	0.0135	CcSEcCtD
Methylscopolamine bromide—Constipation—Lisinopril—dilated cardiomyopathy	0.00505	0.0131	CcSEcCtD
Methylscopolamine bromide—Vomiting—Furosemide—dilated cardiomyopathy	0.005	0.013	CcSEcCtD
Methylscopolamine bromide—Headache—Furosemide—dilated cardiomyopathy	0.00493	0.0128	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00486	0.0127	CcSEcCtD
Methylscopolamine bromide—Urticaria—Lisinopril—dilated cardiomyopathy	0.00469	0.0122	CcSEcCtD
Methylscopolamine bromide—Nausea—Furosemide—dilated cardiomyopathy	0.00467	0.0122	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00435	0.0113	CcSEcCtD
Methylscopolamine bromide—Asthenia—Lisinopril—dilated cardiomyopathy	0.00424	0.011	CcSEcCtD
Methylscopolamine bromide—Dizziness—Lisinopril—dilated cardiomyopathy	0.0039	0.0102	CcSEcCtD
Methylscopolamine bromide—Vomiting—Lisinopril—dilated cardiomyopathy	0.00375	0.00976	CcSEcCtD
Methylscopolamine bromide—Headache—Lisinopril—dilated cardiomyopathy	0.0037	0.00962	CcSEcCtD
Methylscopolamine bromide—Nausea—Lisinopril—dilated cardiomyopathy	0.00351	0.00912	CcSEcCtD
Methylscopolamine bromide—CHRM5—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00319	0.00604	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00282	0.00533	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.0028	0.0053	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00277	0.00524	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00276	0.00523	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00273	0.00518	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00262	0.00496	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00254	0.0048	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00251	0.00474	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00247	0.00469	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00241	0.00457	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00241	0.00457	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00229	0.00433	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00228	0.00432	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00226	0.00427	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00224	0.00425	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00224	0.00425	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00224	0.00424	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00222	0.00419	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00218	0.00412	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00217	0.00411	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00217	0.0041	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00211	0.00399	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00211	0.00399	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00205	0.00389	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00198	0.00375	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00198	0.00374	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00197	0.00374	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00197	0.00373	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00197	0.00372	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00196	0.00371	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00196	0.00371	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00189	0.00357	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00186	0.00351	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00184	0.00349	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00184	0.00348	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00184	0.00348	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00184	0.00348	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00182	0.00345	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00179	0.00338	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00178	0.00337	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00176	0.00334	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00176	0.00334	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00176	0.00334	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00176	0.00333	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00176	0.00333	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00174	0.0033	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00174	0.00329	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00172	0.00326	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00171	0.00323	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0017	0.00322	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0017	0.00322	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00169	0.00321	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00169	0.00321	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00168	0.00318	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00168	0.00318	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00165	0.00313	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00164	0.00311	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00158	0.00299	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00157	0.00298	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00156	0.00295	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00153	0.0029	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00153	0.00289	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00153	0.00289	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00152	0.00288	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00151	0.00286	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00151	0.00285	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00145	0.00274	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00144	0.00273	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00143	0.0027	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00141	0.00268	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.0014	0.00265	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00139	0.00263	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00138	0.00262	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00134	0.00254	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00131	0.00247	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00131	0.00247	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0013	0.00247	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00129	0.00245	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00129	0.00245	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00129	0.00244	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00129	0.00244	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00129	0.00244	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00128	0.00242	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00128	0.00242	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00125	0.00237	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00124	0.00235	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00124	0.00235	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00124	0.00234	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00124	0.00234	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00122	0.00232	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00122	0.00232	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0012	0.00228	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0012	0.00227	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00119	0.00225	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.00117	0.00222	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00117	0.00221	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00116	0.0022	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00116	0.00219	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00115	0.00218	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00115	0.00218	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00114	0.00216	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00114	0.00216	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00113	0.00213	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.00106	0.00201	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00104	0.00197	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00104	0.00197	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000995	0.00188	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000994	0.00188	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000992	0.00188	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000982	0.00186	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000965	0.00183	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000944	0.00179	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000943	0.00179	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000943	0.00179	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000941	0.00178	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000935	0.00177	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000932	0.00176	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000919	0.00174	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000917	0.00174	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000908	0.00172	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000877	0.00166	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000862	0.00163	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000859	0.00163	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000849	0.00161	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000839	0.00159	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000799	0.00151	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000792	0.0015	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00079	0.0015	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000782	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000758	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000731	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000731	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000729	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000729	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000725	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000722	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000722	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000718	0.00136	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.0007	0.00133	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000698	0.00132	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000691	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000688	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00068	0.00129	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000678	0.00128	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000671	0.00127	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000664	0.00126	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000664	0.00126	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000662	0.00125	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000662	0.00125	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000658	0.00125	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000656	0.00124	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000655	0.00124	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000655	0.00124	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00065	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000627	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000617	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000615	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000609	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000598	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000596	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000591	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00059	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000589	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000588	0.00111	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000562	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000562	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00056	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000557	0.00105	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000557	0.00105	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000555	0.00105	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000534	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000533	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000532	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000527	0.000997	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000518	0.000981	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000511	0.000967	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00051	0.000966	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000509	0.000964	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000504	0.000954	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000502	0.00095	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000484	0.000917	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000483	0.000914	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000478	0.000905	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000442	0.000836	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00044	0.000834	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000436	0.000826	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000428	0.000811	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000414	0.000784	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000413	0.000782	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000409	0.000774	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000406	0.000769	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000396	0.000749	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000394	0.000747	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000392	0.000743	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000392	0.000743	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000391	0.00074	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000391	0.00074	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000391	0.000739	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000387	0.000733	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000387	0.000733	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000376	0.000712	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000375	0.00071	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000371	0.000703	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000365	0.00069	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000364	0.000688	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00036	0.000682	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000359	0.00068	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000358	0.000678	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000355	0.000671	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000354	0.00067	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000353	0.000669	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000352	0.000667	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000349	0.000661	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000349	0.00066	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000316	0.000597	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000302	0.000571	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	0.000301	0.000571	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000301	0.000569	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000298	0.000564	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.000289	0.000546	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000286	0.000542	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000285	0.00054	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000282	0.000535	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CD36—dilated cardiomyopathy	0.000281	0.000532	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AGT—dilated cardiomyopathy	0.000253	0.000479	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000249	0.000472	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000249	0.000471	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000246	0.000466	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000246	0.000466	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000245	0.000464	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000243	0.00046	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000243	0.00046	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000222	0.000421	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000221	0.000419	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000219	0.000415	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000212	0.000402	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000212	0.000401	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.00021	0.000397	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000209	0.000396	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000171	0.000324	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00017	0.000323	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000169	0.00032	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000147	0.000279	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000147	0.000278	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000145	0.000275	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000143	0.000272	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000101	0.000191	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000101	0.000191	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	9.97e-05	0.000189	CbGpPWpGaD
